BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 5774189)

  • 1. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and destruction of prothrombin in the rat.
    Bell RG; Matschiner JT
    Arch Biochem Biophys; 1969 Dec; 135(1):152-9. PubMed ID: 5362918
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the activity of the cis and trans isomer of vitamin K1 in vitamin K-deficient and coumarin anticoagulant-pretreated rats.
    Lowenthal J; Vergel Rivera GM
    J Pharmacol Exp Ther; 1979 Jun; 209(3):330-3. PubMed ID: 439009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal by vitamin K of cycloheximide inhibited biosynthesis of prothrombin in the isolated perfused rat liver.
    Kipfer RK; Olson RE
    Biochem Biophys Res Commun; 1970 Mar; 38(6):1041-8. PubMed ID: 5437347
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K and prothrombin synthesis.
    Suttie JW
    Nutr Rev; 1973 Apr; 31(4):105-9. PubMed ID: 4578889
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of oral anticoagulants].
    Richter M; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):8-17. PubMed ID: 433362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of prothrombin biosynthesis in cell-free systems. 3. Regulation by vitamin K and warfarin of prothrombin biosynthesis in rat liver microsomes.
    Johnston MF; Olson RE
    J Biol Chem; 1972 Jun; 247(12):4001-7. PubMed ID: 5033399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.